Rep. Daniel Webster

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.

Maddy summaryThe Educational Choice for Children Act creates tax credits for individuals and corporations that contribute to scholarship granting organizations providing education scholarships. Individuals can claim a credit up to $5,000 or 10% of their income, while corporations can claim up to 5% of taxable income. The scholarships are available to students from households with income up to 300% of the area median income, and can be used for private school tuition, tutoring, and other educational expenses at elementary and secondary schools. The bill includes strict requirements for scholarship organizations to verify income, conduct audits, and prevent misuse of funds, while also prohibiting government control over these organizations and protecting private and religious schools from discrimination in the program. It establishes a $10 billion annual cap on the total tax credits available.

Maddy summaryThis bill requires healthcare providers to give the same medical care to infants born alive during abortions as they would to any newborn, and to immediately admit such infants to a hospital. It mandates reporting of non-compliance to law enforcement and imposes penalties including up to 5 years in prison for violations. Women who undergo abortions can file civil lawsuits seeking money damages for injuries, three times the abortion cost, and punitive damages if care standards are not met. The bill also clarifies that abortion includes intentionally killing an unborn child or terminating pregnancy without specific exceptions (e.g., after viability to preserve life or removing a dead fetus).

Maddy summaryHR 22, the *Protecting America’s Strategic Petroleum Reserve from China Act*, blocks the U.S. government from selling petroleum from the Strategic Petroleum Reserve to entities under Chinese Communist Party control or unless sellers guarantee the oil won’t be exported to China. It directly affects the Department of Energy’s management of the reserve and any foreign entities seeking to purchase reserve petroleum. The key mechanism requires the Secretary of Energy to prohibit sales to China-linked entities or impose strict export restrictions on any sale. This policy change aims to prevent strategic petroleum resources from reaching entities tied to China’s government.

Maddy summaryHR 175, the Heartbeat Protection Act of 2023, prohibits physicians from performing abortions without first checking for a detectable fetal heartbeat using standard medical practice and informing the patient of the results. It allows exceptions only for abortions necessary to save a mother’s life due to physical conditions (not psychological ones), or for pregnancies resulting from rape or incest against an adult or minor, which require specific documentation like counseling records or police reports. Physicians violating the law face up to five years in prison, while patients cannot be prosecuted. The bill defines "unborn child" as beginning at fertilization and mandates detailed medical documentation for all exceptions. It explicitly excludes psychological conditions from life-threatening exceptions and requires physicians to retain records per federal health privacy rules.

Maddy summaryHCONRES 3 is a non-binding congressional resolution expressing support for pro-life facilities, groups, and churches targeted by vandalism and threats following the Supreme Court's Dobbs decision. It condemns specific incidents like graffiti, window-smashing, and arson at pregnancy centers and churches (e.g., in Frederick, MD, and Portland, OR), while recognizing the role of these organizations in supporting pregnant women. The resolution calls on the Biden Administration to use law enforcement to protect these facilities but does not create new laws or policies. As a symbolic measure, it has no legal effect on the incidents described.

Maddy summaryThis bill blocks federal funding for colleges that operate or partner with campus health clinics providing abortion drugs or abortions to students or staff. It requires institutions receiving federal funds to annually certify that no such services are offered at their on-campus clinics. The law specifically excludes hospital-based clinics from coverage and defines "abortion drugs" as medications intended to terminate pregnancy (excluding specific medical exceptions). It directly affects public and private colleges receiving federal aid, as most institutions of higher education qualify for such funding.

Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.

Maddy summaryHR 279, the Pharmacist Conscience Protection Act, protects pharmacists, pharmacy technicians, and pharmacy owners who refuse to dispense medications approved for abortion or that they believe may be used for abortion, based on moral, religious, or medical objections. The bill prohibits federal agencies and entities receiving federal funds (including state/local governments) from discriminating against, penalizing, or retaliating against these providers for such refusals. It does not require pharmacists to dispense these medications and explicitly preserves stronger state conscience protections. This law directly affects pharmacists and pharmacies seeking to align their practice with personal or religious beliefs regarding abortion-related medications.